Adial Pharmaceuticals(ADIL) - 2025 Q1 - Quarterly Results

Form 8-K Current Report This report details significant events or information that shareholders should be aware of, as required by the Securities Exchange Act Item 2.02. Results of Operations and Financial Condition This section details the company's financial results for the quarter ended March 31, 2025, as announced in a press release, noting its 'furnished' status under the Exchange Act - The company issued a press release on May 15, 2025, which included financial information for the quarter ended March 31, 2025[5] - The press release is attached as Exhibit 99.1 to the Form 8-K report[5] - The information furnished in this report, including Exhibit 99.1, is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into any other SEC filings[6] Item 9.01. Financial Statements and Exhibits This section provides a comprehensive list of exhibits accompanying the Form 8-K, including the financial press release and interactive data file List of Exhibits | Exhibit Number | Description | | :--- | :--- | | 99.1 | Press Release issued by Adial Pharmaceuticals, Inc., dated May 15, 2025 | | 104 | Cover Page Interactive Data File (embedded within the XBRL document) |